Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy
This article is from
The Cancer Letter
archive.
Vol. 30 No. 10 | October 26, 2007
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC
February 26, 2010
TCL Archive
RFOs Available, Contract Awards, Sole Source Negotiations
February 3, 1978
TCL Archive
NCI selects nanotech centers for funding.
October 14, 2005
TCL Archive
Cooperative Groups Cut In On $1 Million Head 7 Neck Projects
March 25, 1977
TCL Archive
No Cancer Letter For Next Two Weeks
August 30, 1991
TCL Archive
Eleven Chemicals Rated for Tests
September 1, 1978
